Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders

N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders

US Patent 7795440 · Granted Sep 14, 2010

Estimated economic value: $62,961,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo-pyrimidines and uses thereof2025
PRMT5 inhibiting compounds and uses thereof2025
Ketone inhibitors of lysine gingipain2024
Cyclic dinucleotides as sting agonists2023
Cyclic dinucleotides as sting agonists2022
Cyclic dinucleotides as sting agonists2022
Ketone inhibitors of lysine gingipain2022
Aminopyridine compounds and methods for the preparation and use thereof2021
Cyclic dinucleotides as sting agonists2021
Bispecific EGFR/IGFIR binding molecules2021
Bioorthogonal compositions2020
Targeted therapeutics based on engineered proteins that bind EGFR2020